These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 15520162

  • 1. Aberrant and alternative splicing in cancer.
    Venables JP.
    Cancer Res; 2004 Nov 01; 64(21):7647-54. PubMed ID: 15520162
    [Abstract] [Full Text] [Related]

  • 2. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A, Turpaz Y.
    BMC Genomics; 2006 Dec 27; 7():325. PubMed ID: 17192196
    [Abstract] [Full Text] [Related]

  • 3. Splice variants as cancer biomarkers.
    Brinkman BM.
    Clin Biochem; 2004 Jul 27; 37(7):584-94. PubMed ID: 15234240
    [Abstract] [Full Text] [Related]

  • 4. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A, Martignetti JA, Narla G.
    Drug Resist Updat; 2009 Jul 27; 12(1-2):1-7. PubMed ID: 19097929
    [Abstract] [Full Text] [Related]

  • 5. Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2.
    Kaufmann D, Leistner W, Kruse P, Kenner O, Hoffmeyer S, Hein C, Vogel W, Messiaen L, Bartelt B.
    Cancer Res; 2002 Mar 01; 62(5):1503-9. PubMed ID: 11888927
    [Abstract] [Full Text] [Related]

  • 6. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.
    Keller KE, Kelley MJ, Acott TS.
    Invest Ophthalmol Vis Sci; 2007 Mar 01; 48(3):1164-72. PubMed ID: 17325160
    [Abstract] [Full Text] [Related]

  • 7. [A progress toward research on alternative splicing of genes in tumor cells].
    Zhou ZR, Sun KL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr 01; 23(2):177-80. PubMed ID: 16604490
    [Abstract] [Full Text] [Related]

  • 8. Alternative pre-mRNA splicing in digestive tract malignancy.
    Miura K, Fujibuchi W, Sasaki I.
    Cancer Sci; 2011 Feb 01; 102(2):309-16. PubMed ID: 21134075
    [Abstract] [Full Text] [Related]

  • 9. Identification of alternative splicing markers for breast cancer.
    Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, Gervais-Bird J, Lapointe E, Froehlich U, Durand M, Gendron D, Brosseau JP, Thibault P, Lucier JF, Tremblay K, Prinos P, Wellinger RJ, Chabot B, Rancourt C, Elela SA.
    Cancer Res; 2008 Nov 15; 68(22):9525-31. PubMed ID: 19010929
    [Abstract] [Full Text] [Related]

  • 10. Alternative splicing in cancer: noise, functional, or systematic?
    Skotheim RI, Nees M.
    Int J Biochem Cell Biol; 2007 Nov 15; 39(7-8):1432-49. PubMed ID: 17416541
    [Abstract] [Full Text] [Related]

  • 11. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM, Saraco NI, Baquedano MS, Guercio G, Vaiani E, Marino R, Pandey AV, Flück CE, Rivarola MA, Belgorosky A.
    Clin Endocrinol (Oxf); 2007 Nov 15; 67(5):698-705. PubMed ID: 17608756
    [Abstract] [Full Text] [Related]

  • 12. Alterations of pre-mRNA splicing in cancer.
    Kalnina Z, Zayakin P, Silina K, Linē A.
    Genes Chromosomes Cancer; 2005 Apr 15; 42(4):342-57. PubMed ID: 15648050
    [Abstract] [Full Text] [Related]

  • 13. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells.
    Ortiz RM, Kärkkäinen I, Huovila AP.
    Genes Chromosomes Cancer; 2004 Dec 15; 41(4):366-78. PubMed ID: 15384173
    [Abstract] [Full Text] [Related]

  • 14. Genome-wide detection of testis- and testicular cancer-specific alternative splicing.
    He C, Zuo Z, Chen H, Zhang L, Zhou F, Cheng H, Zhou R.
    Carcinogenesis; 2007 Dec 15; 28(12):2484-90. PubMed ID: 17724370
    [Abstract] [Full Text] [Related]

  • 15. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [Abstract] [Full Text] [Related]

  • 16. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K, Roca X, Beiglböck H, Callens T, Etzler J, Rao AR, Krainer AR, Fonatsch C, Messiaen L.
    Hum Mutat; 2007 Jun 15; 28(6):599-612. PubMed ID: 17311297
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C, Krieger S, Vezain M, Rousselin A, Tournier I, Martins A, Berthet P, Chevrier A, Dugast C, Layet V, Rossi A, Lidereau R, Frébourg T, Hardouin A, Tosi M.
    J Med Genet; 2008 Jul 15; 45(7):438-46. PubMed ID: 18424508
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS, Shen CY, Wang HW, Wu PE, Cheng CW.
    Clin Chim Acta; 2007 Sep 15; 384(1-2):69-74. PubMed ID: 17651715
    [Abstract] [Full Text] [Related]

  • 20. The effect of disease-associated HRPT2 mutations on splicing.
    Hahn MA, McDonnell J, Marsh DJ.
    J Endocrinol; 2009 Jun 15; 201(3):387-96. PubMed ID: 19332451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.